FDA Inspection 745815 — Catalent Pharma Solutions
The FDA completed an inspection of Catalent Pharma Solutions on Oct 4, 2011 in Allendale, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 4, 2011
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Allendale, NJ (United States)